
    
      The purpose of this study is to analyze data available in the PIs Regenerative Orthobiologics
      Registry (ROR) and corresponding patient charts that will either support or refute the
      efficacy of Intra-annular fibrin as treatment for moderate to severe low back pain.
      Additionally, we seek to retrospectively identify possible predisposing factors that are
      correlated with positive outcomes with respect to patient-reported pain and function.
    
  